Robert Kuhl

Robert Kuhl currently serves as a Project Financial Analyst at Fortrea since July 2023, following a seven-year tenure as a Financial Analyst at Labcorp Drug Development, where responsibilities included managing project setups and analyzing Earned Value Analysis reports. Prior experience includes a long-standing role at Oxford Instruments Healthcare, where Robert excelled as a Business/Financial Analyst, leading service period closings and enhancing auditing processes. Additional roles included Cost Accountant and Customer Service and Sales Administrator at the same company, where significant improvements were made in inventory reporting and customer relationships. Robert Kuhl holds an Associate of Science degree in Business Administration from Middlesex County College and has furthered education at Kean University.